Alcohol and Substance Use in Liver Transplant Patients

Clinics in Liver Disease

Volumn 15, Issue 4, 2011, Pages 727-751

  DiMartini, Andrea ^a   Crone, Catherine ^b   Dew, Mary Amanda ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol use; Liver transplant patients; Substance use

Indexed keywords

ACAMPROSATE; AMFEBUTAMONE; BUPRENORPHINE; CYCLOSPORIN; DISULFIRAM; NALOXONE; NALTREXONE; NICOTINE; NICOTINE GUM; NICOTINE PATCH; PLACEBO; TACROLIMUS; VARENICLINE;

ADDICTION; ALCOHOL LIVER DISEASE; ALCOHOLISM; ANXIETY; CHEMOTHERAPY INDUCED EMESIS; DIARRHEA; DIZZINESS; DREAM; DRUG ANTAGONISM; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DYSPNEA; END STAGE LIVER DISEASE; FLUSHING; GASTROINTESTINAL SYMPTOM; HEALTH INSURANCE; HEART PALPITATION; HEMODYNAMICS; HEPATITIS C; HUMAN; HYPERTENSION; HYPOTENSION; INSOMNIA; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; LIVER TOXICITY; LIVER TRANSPLANTATION; MEDICAL ETHICS; NAUSEA; NEOPLASM; REHABILITATION CARE; RELAPSE; REVIEW; SIDE EFFECT; SMOKING; SUBSTANCE ABUSE; SWEATING; TACHYCARDIA; THORAX PAIN; TOBACCO DEPENDENCE; VASCULAR DISEASE;

ALCOHOL DRINKING; END STAGE LIVER DISEASE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER TRANSPLANTATION; MALE; MENTAL HEALTH; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RECURRENCE; SEX FACTORS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; WAITING LISTS;

EID: 80054920328     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2011.08.002     Document Type: Review

References (124)

1. European Liver Transplant Registry. Data on recipients. Available at: Accessed March 21, 2011. http://www.eltr.org/.
2. Lucey M.R., Schaubel D.E., Guidinger M.K., et al. Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit. Hepatology 2009, 50:400-406.
3. 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1996-2008. Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD. Available at: Accessed August 18, 2011. http://optn.transplant.hrsa.gov/ar2009/.
4. Beresford T.P. Psychiatric assessment of alcoholic candidates for liver transplantation. Liver transplantation and the alcoholic patient: medical, surgical, and psychosocial issues 1994, 29-49. Cambridge University Press, Cambridge (United Kingdom). M.R. Lucey, R.M. Merion, T.P. Beresford (Eds.).
5. DiMartini A., Beresford T. Alcoholism and liver transplantation. Curr Opin Organ Transplant 1999, 4:117-181.
6. Diehl A.M. Alcoholic liver disease. Liver transplantation and surgery 1997, 3(3):206-211.
7. The Substance Abuse and Mental Health Services Administration (SAMHSA), agency of the U.S. Department of Health and Human Services (HHS), 2009 annual report. Available at: Accessed August 18, 2011. http://oas.samhsa.gov/NSDUHlatest.htm.
8. Grant B.F. Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey. J Stud Alcohol 1997, 58(5):464-473.
9. Kessler R.C., Berglund P., Demler O., et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593-602.
10. Centers for Disease Control Prevention. Hepatitis C FAQs for health professionals. Available at: Accessed March 21, 2011. http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm%23section1.
11. National Survey on Drug Use and Health Report. 2009. The NSDUH Report is published periodically by the Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA). Available at: Accessed March 22, 2011. http://oas.samhsa.gov.
12. DiMartini A., Dew M.A., Javed L., et al. The pretransplant psychiatric and medical comorbidity of alcoholic liver disease patients who received liver transplant. Psychosomatics 2004, 45(6):517-523.
13. Weinrieb R.M., Van Horn D.H., McLellan A.T., et al. Drinking behavior and motivation for treatment among alcohol dependent liver transplant candidates. J Addict Dis 2001, 20(2):105-119.
14. Weinrieb R.M., Van Horn D.H., McLellan A.T., et al. Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed. Psychosomatics 2001, 42(2):111-115.
15. DiMartini A., Javed L., Russell S., et al. Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl 2005, 11(6):679-683.
16. Ehlers S.L., Rodrigue J.R., Widows M.R., et al. Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research. Liver Transpl 2004, 10:412-417.
17. Ethics Committee, United Network for Organ Sharing General principles for allocating human organs and tissues. Transplant Proc 1992, 24:2227-2235.
18. Pungpapong S., Manzarbeitia C., Ortiz J., et al. Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Liver Transpl 2002, 8:582-587.
19. van der Heide F., Dijkstra G., Porte R.J., et al. Smoking behavior in liver transplant recipients. Liver Transpl 2009, 15(6):648-655.
20. Duvoux C., Delacroix I., Richardet J., et al. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation 1999, 67:418-421.
21. Everhart J.E., Beresford T.P. Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States. Liver Transpl Surg 1997, 3:220-226.
22. Day E., Best D., Sweeting R., et al. Detecting lifetime alcohol problems in individuals referred for liver transplantation for nonalcoholic liver failure. Liver Transpl 2008, 14(11):1609-1613.
23. Neuberger J., Schulz K.H., Day C., et al. Transplantation for alcoholic liver disease. J Hepatol 2002, 36:130-137.
24. Weinrieb R.M., Lucey M.R. Treatment of addictive behaviors in liver transplant patients. Liver Transpl 2007, 13:S79-S82.
25. Cupples S.A., Steslow B. Use of behavioral contingency contracting with heart transplant candidates. Prog Transplant 2001, 11:137-144.
26. Nelson M.K., Presberg B.A., Olbrisch M.E., et al. Behavioral contingency contracting to reduce substance abuse and other high-risk health behaviors in organ transplant patients. J Transpl Coord 1995, 5:35-40.
27. Campbell D.A., Punch J.D. Monitoring for alcohol use relapse after liver transplantation for alcoholic liver disease. Liver Transpl Surg 1997, 3(3):300-303.
28. Murray K.L., Carithers R.F. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005, 41(6).
29. O'Shea R.S., Dasarathy S., McCullough A.J., the Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology AASLD practice guidelines alcoholic liver disease. Hepatology 2010, 51(1):307-328.
30. Lucey M.R., Brown K.A., Everson G.E., et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997, 3(6):628-637.
31. McLellan A.T. Evolution in addiction treatment concepts and methods. The American Psychiatric Publishing textbook of substance abuse treatment 2008, 93-108. American Psychiatric Publishing Inc, Washington, DC. 4th edition. M. Galanter, H.D. Kleber (Eds.).
32. Tonigan JS. Alcoholics anonymous outcomes and benefits, in recent developments in alcoholism. In: Galanter M, Kaskutas LA, editors. Research on alcoholics anonymous and spirituality in addiction recovery, vol. 18. New York: Springer; p. 357-72.
33. Weinrieb R.M., Van Horn D., Lynch K.G., et al. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transpl 2011, 17:539-547.
34. Georgiou G., Webb K., Griggs K., et al. First report of a psychosocial intervention for patients with alcohol related liver disease undergoing liver transplantation. Liver Transpl 2003, 9(7):772-775.
35. Rosner S., Hackl-Herrwerth A., Leucht S., et al. Acamprosate for alcohol dependence. Cochrane Database Syst Rev 2010, 9. CD004332.
36. Ross S., Peselow E. Pharmacotherapy of addictive disorders. Clin Neuropharmacol 2009, 32:277-289.
37. DiMartini A.F., Crone C.C., Fireman M. Organ transplantation. Clinical manual of psychopharmacology in the medically ill 2010, 469-499. American Psychiatric Publishing, Washington, DC. S.J. Ferrando, J.L. Levenson, J.A. Owen (Eds.).
38. Chick J. Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Saf 1999, 20(5):427-435.
39. Berglund M. A better widget? Three lessons learned for improving addiction treatment from a meta-analytical study. Addiction 2005, 11:742-750.
40. Krampe H., Ehrenreich H. Supervised disulfuram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des 2010, 16:2076-2090.
41. Beresford T.P., Martin B. The evidence for drug treatment of alcohol dependence in liver transplant patients. Curr Opin Organ Transplant 2007, 12:176-181.
42. Garbutt J.C. Efficacy and tolerability of naltrexone in the management of alcohol dependence. Curr Pharm Des 2010, 16:2091-2097.
43. Garbutt J.C., Kranzler H.R., O'Malley S.S., et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence. JAMA 2005, 293:1617-1625.
44. Minozzi S., Amato L., Vecchi S., et al. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev 2011, 4.
45. Kahan M., Srivastava A., Ordean A., et al. Buprenorphine: new treatment of opioid addiction in primary care. Can Fam Physician 2011, 57:281-289.
46. Herve S., Riachi G., Noblet C., et al. Acute hepatitis due to buprenorphine administration. Eur J Gastroenterol Hepatol 2004, 16:1033-1037.
47. Zuin M., Giogini A., Selmi C., et al. Acute liver and renal failure during treatment with buprenorphine at therapeutic dose. Dig Liver Dis 2009, 41:e8-e10.
48. Wedam E.F., Bigelow G.E., Johnson R.E., et al. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med 2007, 167:2469-2475.
49. Bogenschutz M.P., Abbott P.J., Kushner R., et al. Effects of buprenorphine and hepatitis C on liver enzymes in adolescents and young adults. J Addict Med 2010, 4:211-216.
50. Bright R.P. Denial of hepatic transplantation on the basis of smoking: is it ethical?. Curr Opin Organ Transplant 2010, 15:249-253.
51. Herman A.I., Sofuoglu M. Comparison of available treatments for tobacco addiction. Curr Psychiatry Rep 2010, 12:433-440.
52. McNeil J.J., Piccenna L., Ioannides-Demos L.L. Smoking cessation: recent advances. Cardiovasc Drugs Ther 2010, 24:359-367.
53. Moss A., Siegler M. Should alcoholics compete equally for liver transplantation?. JAMA 1991, 265:1296-1298.
54. Hays J.T., Ebbert J.O. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence. Drugs 2010, 70:2357-2372.
55. Crone C.C., Marcangelo M., Lackamp J., et al. Gastrointestinal disorders. Clinical manual of psychopharmacology in the medically ill 2010, 103-148. American Psychiatric Publishing Inc, Washington, DC. S.J. Ferrando, J.L. Levenson, J.A. Owen (Eds.).
56. Cuadrado A., Fabrega E., Casafont F., et al. Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2005, 11:420-426.
57. Boshier A., Wilton L.V., Shakir S.A. Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practices in England in 2000. Eur J Clin Pharmacol 2003, 59:767-773.
58. Hughes J.R., Stead L.F., Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007, 1. CD000031.
59. Cahill K., Stead L.F., Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2011, 2:CD006103.
60. DiMartini A., Dew M.A., Day N., et al. Trajectories of alcohol consumption following liver transplantation. Am J Transplant 2010, 10(10):2305-2312.
61. Purvis T.L., Nelson L.A., Mambourg S.E. Varenicline use in patients with mental illness: an update of the evidence. Expert Opin Drug Saf 2010, 9:471-482.
62. Warner E.A., Sharma N. Laboratory diagnosis. Principles of addiction medicine 2009, 295-304. Lippincott Williams & Wilkins, Philadelphia. 4th edition. R.K. Ries, D.A. Fiellin, S.C. Miller (Eds.).
63. DiMartini A., Day N., Lane T., et al. Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease. Alcohol Clin Exp Res 2001, 25(12):1729-1733.
64. Haller D.H., Acosta M.C., Lewis D., et al. Hair analysis versus conventional methods of drug testing in substance abusers seeking organ transplantation. Am J Transplant 2010, 10:1305-1311.
65. DiMartini A., Day N., Dew M., et al. Alcohol use following liver transplantation: a comparison of follow-up methods. Psychosomatics 2001, 42:55-62.
66. Julapalli V.R., Kramer J.R., El-Serag H.B. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large veterans affairs center. Liver Transpl 2005, 11:1370-1378.
67. Kotlyar D.S., Burke A., Campbell M.S., et al. Critical review of candidacy for orthotopic liver transplantation in alcoholic liver disease. Am J Gastroenterol 2008, 103:734-743.
68. Bryce C.L., Angus D.C., Arnold R.M., et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant 2009, 9:2092-2101.
69. Cahill K., Stead L.F., Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2010, 2. CD006103.
70. Douglas D. Should everyone have equal access to organ transplantation? An argument in favor. Arch Intern Med 2003, 163(16):1883-1885.
71. Dumortier J., Guillaud O., Adham M., et al. Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center. Am J Gastroenterol 2007, 102:1032-1041.
72. Neuberger J. Public and professional attitudes to transplanting alcoholic patients. Liver Transpl 2007, 13(11 Suppl 2):S65-S68.
73. Veldt B.J., Lainé F., Guillygomarc'h A., et al. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol 2002, 36:93-98.
74. Moss A.H., Siegler M. Should alcoholics compete equally for liver transplantation?. JAMA 1991, 265(10):1295-1298.
75. Ubel P., Jepson C., Baron J., et al. Allocation of transplantable organs: do people want to punish patients for causing their illness?. Liver Transpl 2001, 7(7):600-607.
76. Neuberger J., Adams D., MacMaster P., et al. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians. BMJ 1998, 317:172-175.
77. McMaster P. Transplantation for alcoholic liver disease in an era of organ shortage. Lancet 2000, 355:424-425.
78. Snyder S.L., Drooker M., Strain J. A survey estimate of academic liver transplant teams' selection practices for alcohol-dependent applicants. Psychosomatics 1996, 37:432-437.
79. OPTN/UNOS Ethics Committee general considerations in assessment for transplant candidacy. Available at: Accessed March 30, 2011. http://optn.transplant.hrsa.gov/resources/bioethics.asp?index=10.
80. Webb K., Shepherd L., Day E., et al. Transplantation for alcoholic liver disease: report of a consensus meeting. Liver Transplant 2006, 12:301-305.
81. Ho D. When good organs go to bad people. Bioethics 2008, 22(2):77-83.
82. Webb K., Shepherd L., Day E., et al. Transplantation for alcoholic liver disease: report of a consensus meeting. Liver Transpl 2006, 12:301-305.
83. Vaillant G.E. The natural history of alcoholism and its relationship to liver transplantation. Liver Transpl Surg 1997, 3:304-310.
84. Vaillant G.E. A 60-year follow-up of alcoholic men. Addiction 2003, 98:1043-1051.
85. Iasi M.S., Vieira A., Anez C.I., et al. Recurrence of alcohol ingestion in liver transplantation candidates. Transplant Proc 2003, 35(3):1123-1124.
86. Vieira A., Rolim E.G., De Capua A., et al. Relapse of alcohol consumption in liver transplant candidates. Risk factor analysis. Arq Gastroenterol 2007, 44(3):205-209.
87. Weinrieb R., Van Horn D., Lucey M., et al. Interpreting the significance of drinking by alcohol dependent liver transplant patients: fostering candor is the key to recovery. Liver Transpl 2000, 6(6):769-776.
88. Beresford T.P. Predictive factors for alcoholic relapse in the selection of alcohol-dependent persons for hepatic transplant. Liver Transpl Surg 1997, 3(3):280-291.
89. Lim J.K., Keefe E.B. Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver Transpl 2004, 10:S31-S38.
90. Louvet A., Texier F., Dharancy S., et al. A prognostic model predicting the death at 6 months of patients with severe alcoholic hepatitis. Hepatology 2004, 40:274A.
91. Stotts A.L., Dodrill C.L., Kosten T.R. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother 2009, 10(11):1727-1740.
92. Weinrieb R.M., Barnett R., Lynch K.G., et al. A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients. Liver Transpl 2004, 10(1):97-106.
93. Koch M., Banys P. Liver transplantation and opioid dependence. JAMA 2001, 285:1056-1058.
94. Kroeker K.I., Basin V.G., Shaw-Stiffel T., et al. Adult liver transplant survey: policies towards eligibility criteria in Canada and the United States 2007. Liver Int 2008, 28:1250-1255.
95. Jiao M., Greanya E.D., Haque M., et al. Methadone maintenance therapy in liver transplantation. Prog Transplant 2010, 20:209-215.
96. Liu L.U., Schiano T.D., Lau N., et al. Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. Am J Transplant 2003, 3:1273-1277.
97. Kanchana T.P., Kaul V., Manzarbeitia C., et al. Liver transplantation for patients on methadone maintenance. Liver Transplant 2002, 8(9):778-782.
98. Lee D.S., Mathur A.K., Acker W.B., et al. Effects of smoking on survival for patients with end-stage liver disease. J Am Coll Surg 2009, 208(6):1077-1084.
99. Rowe I.A., Webb K., Gunson B.K., et al. The impact of disease recurrence on graft survival following liver transplantation: a single centre experience. Transpl Int 2008, 21:459-465.
100. Belle S.H., Beringer K.C., Deter K.M. Liver transplantation for alcoholic liver disease in the United States 1988 to 1995. Liver Transpl Surg 1997, 3:212-219.
101. Berenguer M., Ferrell L., Watson J., et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000, 32:673-684.
102. Futagawa Y., Terasaki P.I., Waki K., et al. No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data. Am J Transplant 2006, 6:1398-1406.
103. Aguilera V., Berenguer M., Rubín A., et al. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): posttransplantation outcome-comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis. Liver Transpl 2009, 15:79-87.
104. Wiesner R.H., Lombardero M., Lake J.R., et al. Liver transplantation for end-stage alcoholic liver disease: an assessment of outcomes. Liver Transpl Surg 1997, 3(3):231-239.
105. Pereira S.P., Howard L.M., Muiesan P., et al. Quality of life after liver transplantation for alcoholic liver disease. Liver Transpl 2000, 6:762-768.
106. Pageaux G.P., Bismuth M., Perney P., et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?. J Hepatol 2003, 38(5):629-634.
107. Perney P., Bismuth M., Sigaud H., et al. Are preoperative patterns of alcohol consumption predictive of relapse after liver transplantation for alcoholic liver disease?. Transpl Int 2005, 18:1292-1297.
108. DiMartini A., Day N., Dew M.A., et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl 2006, 12:813-820.
109. Dew M.A., DiMartini A.F., Steel J., et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl 2008, 14(2):159-172.
110. Starzl T.E., Van Thiel D., Tzakis A., et al. Liver transplant for alcoholic liver disease. JAMA 1988, 260:2542-2544.
111. Gedaly R., McHugh P.P., Johnston T.D., et al. Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease. Transplantation 2008, 86(8):1090-1095.
112. Bellamy C.O., DiMartini A., Ruppert K., et al. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001, 72(4):619-626.
113. Belle S.H., Beringer K.C., Detre K.M. Liver transplantation for alcoholic liver disease in the United States: 1988 to 1995. Liver Transpl Surg 1997, 3:212-219.
114. Benich J.J. Opioid dependence. Prim Care Clin Office Pract 2011, 38:59-70.
115. Jain A., DiMartini A., Kashyap R., et al. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation 2000, 70:1335-1342.
116. Berlakovich G.A., Langer F., Freundorfer E., et al. General compliance after liver transplantation for alcoholic cirrhosis. Transpl Int 2000, 13(2):129-135.
117. Pfitzmann R., Schwenzer J., Rayes N., et al. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007, 13:197-205.
118. Jimenez C., Manrique A., Marques E., et al. Incidence and risk factors for the development of lung tumors after liver transplantation. Transpl Int 2007, 20:57-63.
119. Dumortier J., Guillaud O., Adham M., et al. Negative impact of De Novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: A retrospective analysis of 305 patients in a single center. Am J Gastroenterol 2007, 102:1032-1041.
120. Watt K.D.S., Pedersen R.A., Kremers W.K., et al. Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology 2009, 137(6):2010-2017.
121. Leithead J.A., Ferguson J.W., Hayes P.C. Smoking-related morbidity and mortality following liver transplantation. Liver Transpl 2008, 14(8):1159-1164.
122. McCallum S., Masterton G. Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria. Alcohol Alcohol 2006, 41(4):358-363.
123. International Early Lung Cancer Action Program Investigators Computed tomographic screening for lung cancer: individualising the benefit of the screening. Eur Respir J 2007, 30(5):843-847.
124. Mathurin P. Is alcoholic hepatitis an indication for transplantation? Current management and outcomes. Liver Transpl 2005, 11:S21-S24.